As GLP-1 use grows, HairSmart expects this to become one of the defining hair loss conversations of the next few years, not because the medications are doing something entirely new to the body, but because they're accelerating causes of hair loss that have existed all along, just rarely discussed in the open
The body also begins storing more visceral fat, which is more metabolically active and more resistant to loss than subcutaneous fat
Arbaclofen, the R-enantiomer of baclofen, has been shown to significantly reduce repetitive grooming behaviors in Fmr1 knockout mice following acute injection, and systemic treatment improved sensory filtering abilities in Cntnap2 knockout rats, suppressing excessive acoustic startle responses (146)
While more research is needed before GLP-1s are used to manage neurodegenerative and cardiovascular disease, the pre-clinical studies look promising